title: [Prognostic significance of proliferation markers in hepatocellular carcinoma (HCC)].
abstract: BACKGROUND
  The prognosis of patients with curatively resectable hepatocellular carcinoma depends mainly on anatomic extent of the tumour and on the general condition of the patient. Given the growing evidence that proliferation indices may be of prognostic significance in hepatocellular carcinomas, identification and quantitation of proliferative capacity may be of prognostic importance.
  
  
  METHODS
  We have compared four different methods to assess proliferation in a series of 193 curatively (R0-) resected hepatocellular carcinomas: Mitotic count, immunohistochemical assessment of the MIB-1- (Ki-67-), Antigen Proliferating Cell Nuclear Antigen (PCNA) and silverstained nucleolar organiser regions (AgNOR). The results obtained were compared with pathohistological stage (according to UICC), Edmondson Grade and with survival rate.
  
  
  RESULTS
  In each carcinoma, we could demonstrate mitotic figures, MIB-1, PCNA and AgNOR dots in variable proportions. Significant statistical correlations were seen between Mitotic Index, the rate of nuclear positivity for MIB-1 and PCNA and the number of AgNOR dots. In univariate survival analysis tumour stage and Edmondson Grade, Mitotic Index, MIB-1 and PCNA Index and mean AgNOR-number were significant patients' survival influencing factors. Performing multivariate Cox survival analysis, Mitotic Index, concomitant cirrhosis, Edmondson Grade and patient age were the only significant independent prognostic factors.
  
  
  CONCLUSIONS
  These results indicated that Mitotic Index is an additional prognostic parameter which could provide auxiliary information for patients' outcome.
authors.affiliation: Institut für Pathologie, Universität Leipzig.
authors.forename: J
authors.initials: J
authors.lastname: Ebelt
authors.forename: M
authors.initials: M
authors.lastname: Neid
authors.forename: A
authors.initials: A
authors.lastname: Tannapfel
authors.forename: H
authors.initials: H
authors.lastname: Witzigmann
authors.forename: J
authors.initials: J
authors.lastname: Hauss
authors.forename: F
authors.initials: F
authors.lastname: Köckerling
authors.forename: C
authors.initials: C
authors.lastname: Wittekind
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D006528:Carcinoma, Hepatocellular / Q000401:mortality / Q000473:pathology* / Q000601:surgery; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D008113:Liver Neoplasms / Q000401:mortality / Q000473:pathology* / Q000601:surgery; D008297:Male; D008875:Middle Aged; D008940:Mitotic Index; D015999:Multivariate Analysis; D009697:Nucleolus Organizer Region; D011379:Prognosis; D018809:Proliferating Cell Nuclear Antigen; D012044:Regression Analysis; D016019:Survival Analysis
chemical_list: D018809:Proliferating Cell Nuclear Antigen